The intrauterine contraceptive device: an often-forgotten and maligned method of contraception
- PMID: 10411781
- DOI: 10.1016/s0002-9378(99)70426-6
The intrauterine contraceptive device: an often-forgotten and maligned method of contraception
Abstract
Although 90% of women at risk for unintended pregnancy in the United States use contraception, <1% of these women use the intrauterine contraceptive device. The mechanism of action of intrauterine contraceptive devices has been controversial, but several studies suggest that interference with sperm migration or function and with fertilization may be the most likely mechanisms. More important, there is lack of compelling evidence that the intrauterine contraceptive device acts as an abortifacient. The risk for pelvic inflammatory disease among users now appears to be extremely low, primarily as a result of better selection of candidates. A levonorgestrel-releasing intrauterine contraceptive device may offer some new therapeutic approaches for the treatment of certain gynecologic disorders. Although women who are not at risk for pelvic inflammatory disease or sexually transmitted diseases are appropriate candidates for the intrauterine contraceptive device, it appears that use can be expanded to selected nulliparous women and women with certain medical conditions.
Similar articles
-
Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.J Obstet Gynaecol Can. 2016 Feb;38(2):182-222. doi: 10.1016/j.jogc.2015.12.002. Epub 2016 Feb 26. J Obstet Gynaecol Can. 2016. PMID: 27032746 English, French.
-
Intrauterine devices and intrauterine systems.Hum Reprod Update. 2008 May-Jun;14(3):197-208. doi: 10.1093/humupd/dmn003. Epub 2008 Apr 9. Hum Reprod Update. 2008. PMID: 18400840 Review.
-
Use of intrauterine devices in nulliparous women.Contraception. 2017 Jun;95(6):529-537. doi: 10.1016/j.contraception.2016.08.011. Epub 2016 Aug 31. Contraception. 2017. PMID: 27591814
-
Acceptability of IUDs is increasing.Netw Res Triangle Park N C. 1992 Oct;13(2):27-30. Netw Res Triangle Park N C. 1992. PMID: 12286082
-
The use of intrauterine contraceptive devices, pelvic inflammatory disease, and Chlamydia trachomatis infection.Am J Obstet Gynecol. 1988 Apr;158(4):956-9. doi: 10.1016/0002-9378(88)90101-9. Am J Obstet Gynecol. 1988. PMID: 3284365 Review.
Cited by
-
Tranexamic acid: a review of its use in the management of menorrhagia.Drugs. 2003;63(13):1417-33. doi: 10.2165/00003495-200363130-00008. Drugs. 2003. PMID: 12825966 Review.
-
In the patient's best interest? Revisiting sexual autonomy and sterilization of the developmentally disabled.West J Med. 2001 Oct;175(4):280-3. doi: 10.1136/ewjm.175.4.280. West J Med. 2001. PMID: 11577067 Free PMC article. Review. No abstract available.
-
Barriers to contraceptive use in product labeling and practice guidelines.Am J Public Health. 2006 May;96(5):791-9. doi: 10.2105/AJPH.2004.040774. Epub 2006 Jan 31. Am J Public Health. 2006. PMID: 16449602 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical